Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
Genes|June 26, 2025
Exploring the Prognostic Potential of circSCORE in Patients with Relapsed/Refractory Mantle Cell LymphomaRuth Salim, Christian Winther Eskelund, Mats Jerkeman, et al.Hemasphere|October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphomaMats Jerkeman, Igor Aurer, Elias Campo, et al.Med (New York, N.Y.)|April 5, 2024
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomasMaare Arffman, Leo Meriranta, Matias Autio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer GroupSven-Erik Olofsson, Torgrim Tandstad, Mats Jerkeman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell LymphomaMatthew J Maurer, Fredrik Ellin, Line Srour, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group StudyJorne Lionel Biccler, Ingrid Glimelius, Sandra Eloranta, et al.Blood Advances|May 22, 2025
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell LymphomaLeo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen, et al.European Journal of Haematology|July 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based studyRasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, et al.Blood Advances|December 19, 2023
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trialMats Jerkeman, Arne Kolstad, Martin Hutchings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphomaNiels S Andersen, Lone B Pedersen, Anna Laurell, et al.Pageof 17